SAL-0104

N/A

Report date: 2022/08/26 14:15:39
NME

Base Information

Drug NameSAL-0104
Drug Alias NameSAL0104胶囊SAL-0104SAL0104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor XIa inhibitors
TargetsCoagulation factor XI
Therapy Area/IndicationsVenous ThrombosisThrombosisVenous Thromboembolism +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSuzhou Genemen Biotech Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShenzhen Salubris Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsVenous ThrombosisThrombosisVenous Thromboembolism +[7] 
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A